14.600
14.60 (0%)
As of Dec 20, 2024
Inhibrx, Inc. [INBX]
Source:
Company Overview
Inhibrx, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using our proprietary modular protein engineering platforms.
Country | United States |
Headquarters | la jolla, california |
Phone Number | (858) 795-4220 |
Industry | manufacturing |
CEO | Mark P. Lappe |
Website | www.inhibrx.com |